Unknown

Dataset Information

0

Using Light for Therapy of Glioblastoma Multiforme (GBM).


ABSTRACT: : Glioblastoma multiforme (GBM) is the most malignant form of primary brain tumour with extremely poor prognosis. The current standard of care for newly diagnosed GBM includes maximal surgical resection followed by radiotherapy and adjuvant chemotherapy. The introduction of this protocol has improved overall survival, however recurrence is essentially inevitable. The key reason for that is that the surgical treatment fails to eradicate GBM cells completely, and adjacent parenchyma remains infiltrated by scattered GBM cells which become the source of recurrence. This stimulates interest to any supplementary methods which could help to destroy residual GBM cells and fight the infiltration. Photodynamic therapy (PDT) relies on photo-toxic effects induced by specific molecules (photosensitisers) upon absorption of photons from a light source. Such toxic effects are not specific to a particular molecular fingerprint of GBM, but rather depend on selective accumulation of the photosensitiser inside tumour cells or, perhaps their greater sensitivity to the effects, triggered by light. This gives hope that it might be possible to preferentially damage infiltrating GBM cells within the areas which cannot be surgically removed and further improve the chances of survival if an efficient photosensitiser and hardware for light delivery into the brain tissue are developed. So far, clinical trials with PDT were performed with one specific type of photosensitiser, protoporphyrin IX, which tends to accumulate in the cytoplasm of the GBM cells. In this review we discuss the idea that other types of molecules which build up in mitochondria could be explored as photosensitisers and used for PDT of these aggressive brain tumours.

SUBMITTER: Vasilev A 

PROVIDER: S-EPMC7071600 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Using Light for Therapy of Glioblastoma Multiforme (GBM).

Vasilev Alex A   Sofi Roba R   Rahman Ruman R   Smith Stuart J SJ   Teschemacher Anja G AG   Kasparov Sergey S  

Brain sciences 20200131 2


<b>:</b> Glioblastoma multiforme (GBM) is the most malignant form of primary brain tumour with extremely poor prognosis. The current standard of care for newly diagnosed GBM includes maximal surgical resection followed by radiotherapy and adjuvant chemotherapy. The introduction of this protocol has improved overall survival, however recurrence is essentially inevitable. The key reason for that is that the surgical treatment fails to eradicate GBM cells completely, and adjacent parenchyma remains  ...[more]

Similar Datasets

| S-EPMC7957592 | biostudies-literature
2009-05-30 | GSE16119 | GEO
| S-EPMC10093719 | biostudies-literature
| S-EPMC4814135 | biostudies-literature
| S-EPMC5360865 | biostudies-literature
| S-EPMC8384724 | biostudies-literature
2013-10-18 | E-GEOD-50923 | biostudies-arrayexpress
2013-10-18 | GSE50923 | GEO
| S-EPMC4217833 | biostudies-literature
| S-EPMC3836797 | biostudies-literature